Genscript Biotech Beneish M-Score Historical Data
The historical data trend for Genscript Biotech's Beneish M-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genscript Biotech Beneish M-Score Chart
|
Genscript Biotech Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Beneish M-Score |
|
Get a 7-Day Free Trial
|
|
|
-2.80 |
-1.86 |
-3.19 |
-2.49 |
-1.23 |
|
Genscript Biotech Semi-Annual Data
|
|
Dec14 |
Jun15 |
Dec15 |
Jun16 |
Dec16 |
Jun17 |
Dec17 |
Jun18 |
Dec18 |
Jun19 |
Dec19 |
Jun20 |
Dec20 |
Jun21 |
Dec21 |
Jun22 |
Dec22 |
Jun23 |
Dec23 |
| Beneish M-Score |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
-3.19 |
- |
-2.49 |
- |
-1.23 |
Competitive Comparison of Genscript Biotech's Beneish M-Score
For the Biotechnology subindustry, Genscript Biotech's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genscript Biotech's Beneish M-Score Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Genscript Biotech's Beneish M-Score distribution charts can be found below:
* The bar in red indicates where Genscript Biotech's Beneish M-Score falls into.
Genscript Biotech Beneish M-Score Calculation
The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.
The M-Score Variables:
The M-score of Genscript Biotech for today is based on a combination of the following eight different indices:
| M | = | -4.84 | + | 0.92 * DSRI | + | 0.528 * GMI | + | 0.404 * AQI | + | 0.892 * SGI | + | 0.115 * DEPI |
| = | -4.84 | + | 0.92 * 1.3598 | + | 0.528 * 0.9962 | + | 0.404 * 1.583 | + | 0.892 * 1.346 | + | 0.115 * 1.0065 |
| - | 0.172 * SGAI | + | 4.679 * TATA | - | 0.327 * LVGI |
| - | 0.172 * 0.8238 | + | 4.679 * 0.056515 | - | 0.327 * 0.7473 |
| = | -1.23 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
| This Year (Dec23) TTM: | Last Year (Dec22) TTM: |
Total Receivables was HK$2,137 Mil.
Revenue was HK$6,557 Mil.
Gross Profit was HK$3,199 Mil.
Total Current Assets was HK$18,377 Mil.
Total Assets was HK$26,454 Mil.
Property, Plant and Equipment(Net PPE) was HK$5,865 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$578 Mil.
Selling, General, & Admin. Expense(SGA) was HK$3,028 Mil.
Total Current Liabilities was HK$3,864 Mil.
Long-Term Debt & Capital Lease Obligation was HK$2,742 Mil.
Net Income was HK$-746 Mil.
Gross Profit was HK$0 Mil.
Cash Flow from Operations was HK$-2,241 Mil.
|
Total Receivables was HK$1,168 Mil.
Revenue was HK$4,871 Mil.
Gross Profit was HK$2,367 Mil.
Total Current Assets was HK$13,741 Mil.
Total Assets was HK$19,825 Mil.
Property, Plant and Equipment(Net PPE) was HK$5,037 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$500 Mil.
Selling, General, & Admin. Expense(SGA) was HK$2,731 Mil.
Total Current Liabilities was HK$4,251 Mil.
Long-Term Debt & Capital Lease Obligation was HK$2,375 Mil.
|
1. DSRI = Days Sales in Receivables Index
Measured as the ratio of Revenue in Total Receivables in year t to year t-1.
A large increase in DSR could be indicative of revenue inflation.
| DSRI | = | (Receivables_t / Revenue_t) | / | (Receivables_t-1 / Revenue_t-1) |
| = | (2137.199 / 6556.554) | / | (1167.701 / 4871.309) |
| = | 0.325964 | / | 0.23971 |
| | = | 1.3598 |
2. GMI = Gross Margin Index
Measured as the ratio of gross margin in year t-1 to gross margin in year t.
Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.
| GMI | = | GrossMargin_t-1 | / | GrossMargin_t |
| = | (GrossProfit_t-1 / Revenue_t-1) | / | (GrossProfit_t / Revenue_t) |
| = | (2367.408 / 4871.309) | / | (3198.527 / 6556.554) |
| = | 0.48599 | / | 0.487837 |
| | = | 0.9962 |
3. AQI = Asset Quality Index
AQI is the ratio of asset quality in year t to year t-1.
Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.
| AQI | = | (1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) | / | (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1) |
| = | (1 - (18377.326 + 5864.73) / 26454.151) | / | (1 - (13740.842 + 5036.554) / 19824.61) |
| = | 0.08362 | / | 0.052824 |
| | = | 1.583 |
4. SGI = Sales Growth Index
Ratio of Revenue in year t to sales in year t-1.
Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.
| SGI | = | Sales_t | / | Sales_t-1 |
| = | Revenue_t | / | Revenue_t-1 |
| = | 6556.554 | / | 4871.309 |
| | = | 1.346 |
5. DEPI = Depreciation Index
Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.
DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.
| DEPI | = | (Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) | / | (Depreciation_t / (Depreciaton_t + PPE_t)) |
| = | (500.196 / (500.196 + 5036.554)) | / | (578.284 / (578.284 + 5864.73)) |
| = | 0.090341 | / | 0.089754 |
| | = | 1.0065 |
Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.
6. SGAI = Sales, General and Administrative expenses Index
The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.
SGA expenses index > 1 means that the company is becoming less efficient in generate sales.
| SGAI | = | (SGA_t / Sales_t) | / | (SGA_t-1 /Sales_t-1) |
| = | (3028.164 / 6556.554) | / | (2731.204 / 4871.309) |
| = | 0.461853 | / | 0.560671 |
| | = | 0.8238 |
7. LVGI = Leverage Index
The ratio of total debt to Total Assets in year t relative to yeat t-1.
An LVGI > 1 indicates an increase in leverage
| LVGI | = | ((LTD_t + CurrentLiabilities_t) / TotalAssets_t) | / | ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1) |
| = | ((2742.114 + 3864.375) / 26454.151) | / | ((2374.656 + 4250.657) / 19824.61) |
| = | 0.249734 | / | 0.334196 |
| | = | 0.7473 |
8. TATA = Total Accruals to Total Assets
Total accruals calculated as the change in working capital accounts other than cash less depreciation.
| TATA | = | (IncomefromContinuingOperations_t | - | CashFlowsfromOperations_t) | / | TotalAssets_t |
| = | (NetIncome_t - NonOperatingIncome_t | - | CashFlowsfromOperations_t) | / | TotalAssets_t |
| = | (-745.656 - 0 | - | -2240.718) | / | 26454.151 |
| | = | 0.056515 |
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Genscript Biotech has a M-score of -1.23 signals that the company is likely to be a manipulator.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:01548 has been successfully added to your